PDF herunterladen
CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(01): 064-069
DOI: 10.1055/s-0041-1726271
Original Article

Microbial Patterns and Antibiotic Susceptibility in Blood Culture Isolates of Septicemia Suspected Children in the Pediatrics Ward of a Tertiary Care Hospital

Muhammad Sarfraz Khan
1   Rawalpindi Medical University, Rawalpindi, Pakistan
,
Arslan Kareem
1   Rawalpindi Medical University, Rawalpindi, Pakistan
,
Kiran Fatima
2   Department of Pathology, Rawalpindi Medical University, Rawalpindi, Pakistan
,
Saima Rauf
3   Department of Gynecology, Royal Bolton Hospital, Farnworth, Bolton, United Kingdom
,
Areeb Khalid
1   Rawalpindi Medical University, Rawalpindi, Pakistan
,
Muhammad Shaheryar Bashir
1   Rawalpindi Medical University, Rawalpindi, Pakistan
› Institutsangaben Funding This study is not supported by any kind of funds.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Objectives This study aims to determine microbial patterns and antibiotic susceptibility to alert clinicians to the emerging pathogens that may pose a threat to the community, especially children.

Materials and Methods This retrospective cross-sectional study was conducted in the Department of Pathology, Holy Family Hospital, Rawalpindi, Pakistan, from July 2019 to December 2019. Two samples were taken from two different sites of each patient at the time of fever (> 100° F) to avoid chances of contamination. A blood sample of 5 to 10 mL was drawn from each site. In a 50 mL brain heart infusion broth (BHIB), 5 to 10% blood was injected in two different bottles and incubated for 48 hours at 37°C. After 48 hours, subculture was done by streaking the drops of blood samples taken from BHIB on blood and MacConkey agar. Cultures were incubated in aerobic conditions at 37°C for 24 to 48 hours. For testing antibiotic susceptibility, criteria defined by the Clinical and Laboratory Standards Institute (CLSI) were followed. Microbes were identified under a microscope by observing their morphological characteristics after gram staining and applying biochemical tests. Antibiotic sensitivity test was performed using standard aseptic methods.

Statistical Analysis Bacterial isolates and their susceptibility patterns were represented using frequencies and percentage charts.

Results Out of 423 blood cultures, growth was recorded in 92 (21.75%) of the cultures with female to male ratio 2.1:1. The gram-positive bacteria accounted for 43.48% (n = 40), whereas gram-negative bacteria covered the majority 54.36% (n = 50). Among isolates, Staphylococcus aureus (42.39%) was the most common, followed by Acinetobacter spp. (17.39%) and Pseudomonas aeruginosa (14.13%). Acinetobacter spp. showed 0% susceptibility to amikacin and cefotaxime. All the isolates were 100% resistant to amoxicillin-clavulanic acid. S. aureus showed lower sensitivity for ceftazidime (0%), clindamycin (66.67%), ciprofloxacin (0%), clarithromycin (11.76%), and ceftriaxone (0%). Tigecycline showed 100% sensitivity for all isolates tested.

Conclusion Gram-negative bacteria form the majority of isolates in our setup, with Acinetobacter as the most common species among them. The resistance against cephalosporins, penicillin, and fluoroquinolones shown by Acinetobacter, Pseudomonas, Salmonella, and Klebsiella is of grave concern. Among gram-positive bacteria, S. aureus has established resistance against multiple drugs. Limited and objective use of antibiotic therapy is a much-needed strategy under new guidelines.

Keywords

antibiotic susceptibility - blood culture - sepsis - pediatrics - Clinical and Laboratory Standards Institute (CLSI)


Publikationsverlauf

Artikel online veröffentlicht:
13. Mai 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence 2014; 5 (01) 213-218
    CrossrefPubMedGoogle Scholar
  • 2 West JPM. Acute Care Handbook. Physical Therapists. 4th Edition 4th ed.. Saunders; 2013. Available at: Accessed Jan 6, 2020
    Google Scholar
  • 3 Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014; 5 (01) 4-11 DOI: 10.4161/viru.27372.
    CrossrefPubMedGoogle Scholar
  • 4 Nielsen SL, Lassen AT, Gradel KO. et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Infect 2015; 70 (02) 111-126
    CrossrefPubMedGoogle Scholar
  • 5 Owais A, Tikmani SS, Sultana S. et al. Incidence of pneumonia, bacteremia, and invasive pneumococcal disease in Pakistani children. Trop Med Int Health 2010; 15 (09) 1029-1036
    PubMedGoogle Scholar
  • 6 Mehdinejad M, Khosravi AD, Morvaridi A. Study of prevalence and antimicrobial susceptibility pattern of bacteria isolated from blood cultures. J Biol Sci 2009; 9: 249-253
    CrossrefGoogle Scholar
  • 7 Husada D, Chanthavanich P, Chotigeat U. et al. Predictive model for bacterial late-onset neonatal sepsis in a tertiary care hospital in Thailand. BMC Infect Dis 2020; 20 (01) 151 DOI: 10.1186/s12879-020-4875-5.
    CrossrefPubMedGoogle Scholar
  • 8 Singh M, Alsaleem M, Gray CP. Neonatal Sepsis. In: StatPearls Treasure Island FL: StatPearls Publishing 2020
  • 9 Weiss SL. Clinical trials in pediatric sepsis: what’s the (end) point?. Pediatr Crit Care Med 2017; 18 (03) 296-297
    CrossrefPubMedGoogle Scholar
  • 10 Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86 (05) 408-416
    CrossrefPubMedGoogle Scholar
  • 11 CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute 2018
  • 12 Lehmann C, Sharawi N., Al-Banna N. Corbett N, Kuethe JW, Caldwell CC. Novel approaches to the development of anti-sepsis drugs. Expert Opin Drug Discov 2014; 9 (05) 523-531
    CrossrefPubMedGoogle Scholar
  • 13 Mohammad A. Bacteremia among Jordanian children at Princess Rahmah Hospital: Pathogens and antimicrobial susceptibility patterns. Iran J Microbiol 2010; 2 (01) 22-26
    PubMedGoogle Scholar
  • 14 Kumarasamy KK, Toleman MA, Walsh TR. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10 (09) 597-602
    CrossrefPubMedGoogle Scholar
  • 15 Fox-Lewis A, Takata J, Miliya T. et al. Antimicrobial resistance in invasive bacterial infections in hospitalized children, Cambodia, 2007-2016. Emerg Infect Dis 2018; 24 (05) 841-851
    CrossrefPubMedGoogle Scholar
  • 16 Prabhu K, Bhat S, Rao S. Bacteriologic profile and antibiogram of blood culture isolates in a pediatric care unit. J Lab Physicians 2010; 2 (02) 85-88
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 17 Pokharel K, Dawadi BR, Bhatt CP, Gupte S. Prevalence of pseudomonas aeruginosa and its antibiotic sensitivity pattern. J Nepal Health Res Counc 2019; 17 (01) 109-113
    CrossrefPubMedGoogle Scholar
  • 18 Ahmad H, Sadiq A, Bhatti HW. et al. Bacteriological profile and antibiogram of cultures isolated from tracheal secretions. Cureus 2019; 11 (06) e4965 DOI: 10.7759/cureus.4965.
    CrossrefPubMedGoogle Scholar
  • 19 Okon K, Agukwe PC, Oladosu W, Balogun ST, Uba A.. Resistance pattern of Pseudomonas aeruginosa isolated from clinical specimens in a Tertiary Hospital in Northeastern Nigeria. Inter J Microbiol 2009; 8: 1-6
  • 20 Shah DA, Wasim S, Essa Abdullah F. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of Urinary Tract Infections patients in Karachi, Pakistan. Pak J Med Sci 2015; 31 (02) 341-345
    PubMedGoogle Scholar